Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

Community pharmacist-led medication review procedures across Europe: Characterization, implementation and remuneration
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
ID 4526635
Author(s) Imfeld-Isenegger, Tamara Leila; Soares, InÍs Branco; Makovec, Urska Nabergoj; Horvat, Nejc; Kos, Mitja; van Mil, Foppe; Costa, Filipa A.; Hersberger, Kurt E.
Author(s) at UniBasel Imfeld-Isenegger, Tamara
Hersberger, Kurt
Year 2020
Title Community pharmacist-led medication review procedures across Europe: Characterization, implementation and remuneration
Journal Research in Social and Administrative Pharmacy
Volume 16
Number 8
Pages / Article-Number 1057-1066
Keywords Community pharmacy services; Europe; Medication review; Primary health care; Remuneration; Service implementation
Abstract Pharmaceutical Care Network Europe (PCNE) proposed a definition and classification system (type 1, 2a, 2b, 3) for medication review in 2016. However, to date, a description of the implementation and remuneration of such procedures across Europe is lacking.; The aim of this study was to describe the medication review procedures and the level of implementation and remuneration in community pharmacies across Europe.; An online survey was developed to characterize medication review procedures (PCNE classification), level of implementation (considering regional or national) and remuneration by a third party. This survey was sent to a purposive sample of three individuals per country, with a working background in community pharmacy, pharmacy practice research, or health policy to ensure reliable data. Data triangulation was used and consensus sought between the responses.; Data were received from 34 out of 44 targeted European countries (November 2016-October 2017) [response rate†=†77%]. Overall, 55.9% of the countries provided at least one type of medication review as an implemented service or project. Type 1 medication review (based on the medication history) was provided in 13 countries, type 2a (medication history†+†patient interview) in 14, type 2b (medication history†+†clinical data) in two, and type 3 medication review (medication history†+†patient interview†+†clinical data) in four countries. Ten of the mentioned services or projects were remunerated by a third-party.; Substantial heterogeneity was observed across Europe in various aspects, including the procedures, implementation level and remuneration obtained. Type 1 and 2a medication review services seem to be more feasible to implement in the community pharmacy than type 2b and 3. A large number of medication review projects were ongoing in community pharmacies, which suggests that new medication review services could become implemented in the coming years.
Publisher Elsevier
ISSN/ISBN 1551-7411 ; 1934-8150
Full Text on edoc No
Digital Object Identifier DOI 10.1016/j.sapharm.2019.11.002
PubMed ID
Document type (ISI) Journal Article

MCSS v5.8 PRO. 0.316 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |